furthermore, arcsa has only approved pfizer biontech, and the only ones that have given any sign of negotiating with private parties are the serum institute of india with astrazeneca. of rest there is no more. the queue is long and only for governments with sufficient leverage. all this uio and gye is a shot in the air.